Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03603730

Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

Modulation of Gastric Sensitivity and Accommodation by Vagal Nerve Stimulation

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
65 (estimated)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Explore the effects of auricular transcutaneous vagal nerve stimulation (taVNS) on brain and stomach outcomes in functional dyspepsia and gastroparesis patients.

Detailed description

The primary aims of this study are to 1) investigate the effects of auricular transcutaneous vagal nerve stimulation (taVNS) on brain-gut signaling using a liquid meal test in functional dyspepsia (FD) and gastroparesis (GP) patients using combined gastric, autonomic and neuroimaging measures, and 2) evaluate the effectiveness of taVNS on FD and GP symptoms. A total of 25 FD and 25 GP patients will be enrolled in this study, both females and males, ranging between 18 and 65 years of age. There will be multiple study visits consisting of a screening, baseline testing, consumption of a liquid meal, and fMRI brain and gut imaging sessions. Visits will include active and inactive taVNS delivered to the outer ear at a moderate, non-painful level.

Conditions

Interventions

TypeNameDescription
DEVICEtaVNSActive or inactive taVNS delivered to the external ear at a moderate, non-painful level.

Timeline

Start date
2018-11-30
Primary completion
2027-06-30
Completion
2028-03-31
First posted
2018-07-27
Last updated
2025-10-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03603730. Inclusion in this directory is not an endorsement.

Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis (NCT03603730) · Clinical Trials Directory